FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898096704> ?p ?o ?g. }

• W2898096704 endingPage "35" @default.
• W2898096704 startingPage "29" @default.
• W2898096704 abstract "Acute myeloid leukemia (AML) in older patients is often associated with biologic and clinical characteristics that predict poor outcomes to cytarabine and anthracycline based induction chemotherapy (IC). The impact of hypomethylating agents (HMA) in the treatment of these high-risk patients is unknown. Here we retrospectively examined the remission rates and survival outcomes of 201 newly diagnosed patients ≥60 years old with therapy-related (t-AML), secondary (s-AML), or AML with myelodysplasia-related changes (AML-MRC). Ninety-eight patients received IC, and 103 received HMA. Patients in the IC cohort were younger than those who received HMA (68 vs. 74 years; p < 0.01) with lower comorbidity burden. Composite complete remission rates (CR) were 39% in IC and 27% in the HMA cohorts (p = 0.10). Overall survival (OS) was not significantly different between the two cohorts (7.59 mos vs. 5.49 mos; HR 0.75 95% CI 0.55–1.02) despite the fact that more patients in the IC cohort (33% versus 5%, p < 0.01) underwent allogeneic stem cell transplant. Patients with t-AML (HR 0.56; 95% CI 0.33–0.97) and complex karyotype without monosomal karyotype (CK + MK-; HR 0.37; 95% CI 0.19–0.75) had better OS following IC. Patients with CK + MK+ (HR 2.00; 95% CI 1.08–3.70) had improved OS following HMA. Our results support the use of HMA as an alternative upfront regimen in older individuals with newly diagnosed high-risk AML based on similar clinical outcomes to IC." @default.
• W2898096704 created "2018-11-02" @default.
• W2898096704 creator A5025571948 @default.
• W2898096704 creator A5038004259 @default.
• W2898096704 creator A5038660651 @default.
• W2898096704 creator A5041712124 @default.
• W2898096704 creator A5046140518 @default.
• W2898096704 creator A5053447705 @default.
• W2898096704 creator A5054956722 @default.
• W2898096704 creator A5060452476 @default.
• W2898096704 creator A5091066647 @default.
• W2898096704 date "2018-12-01" @default.
• W2898096704 modified "2023-10-17" @default.
• W2898096704 title "Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience" @default.
• W2898096704 cites W1972047494 @default.
• W2898096704 cites W1976233870 @default.
• W2898096704 cites W2028142301 @default.
• W2898096704 cites W2028627376 @default.
• W2898096704 cites W2076999892 @default.
• W2898096704 cites W2107027906 @default.
• W2898096704 cites W2117446917 @default.
• W2898096704 cites W2119649565 @default.
• W2898096704 cites W2132027522 @default.
• W2898096704 cites W2144395887 @default.
• W2898096704 cites W2159507916 @default.
• W2898096704 cites W2339658711 @default.
• W2898096704 cites W2551516978 @default.
• W2898096704 cites W2592670191 @default.
• W2898096704 cites W2605196669 @default.
• W2898096704 cites W2621608733 @default.
• W2898096704 cites W2745668487 @default.
• W2898096704 cites W2883399820 @default.
• W2898096704 cites W2979619952 @default.
• W2898096704 cites W4231346141 @default.
• W2898096704 cites W4376595466 @default.
• W2898096704 doi "https://doi.org/10.1016/j.leukres.2018.10.011" @default.
• W2898096704 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7181345" @default.
• W2898096704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30445237" @default.
• W2898096704 hasPublicationYear "2018" @default.
• W2898096704 type Work @default.
• W2898096704 sameAs 2898096704 @default.
• W2898096704 citedByCount "19" @default.
• W2898096704 countsByYear W28980967042019 @default.
• W2898096704 countsByYear W28980967042020 @default.
• W2898096704 countsByYear W28980967042021 @default.
• W2898096704 countsByYear W28980967042022 @default.
• W2898096704 countsByYear W28980967042023 @default.
• W2898096704 crossrefType "journal-article" @default.
• W2898096704 hasAuthorship W2898096704A5025571948 @default.
• W2898096704 hasAuthorship W2898096704A5038004259 @default.
• W2898096704 hasAuthorship W2898096704A5038660651 @default.
• W2898096704 hasAuthorship W2898096704A5041712124 @default.
• W2898096704 hasAuthorship W2898096704A5046140518 @default.
• W2898096704 hasAuthorship W2898096704A5053447705 @default.
• W2898096704 hasAuthorship W2898096704A5054956722 @default.
• W2898096704 hasAuthorship W2898096704A5060452476 @default.
• W2898096704 hasAuthorship W2898096704A5091066647 @default.
• W2898096704 hasBestOaLocation W28980967042 @default.
• W2898096704 hasConcept C104317684 @default.
• W2898096704 hasConcept C121608353 @default.
• W2898096704 hasConcept C126322002 @default.
• W2898096704 hasConcept C143998085 @default.
• W2898096704 hasConcept C150194340 @default.
• W2898096704 hasConcept C185592680 @default.
• W2898096704 hasConcept C190727270 @default.
• W2898096704 hasConcept C2776012956 @default.
• W2898096704 hasConcept C2776239401 @default.
• W2898096704 hasConcept C2776611710 @default.
• W2898096704 hasConcept C2776694085 @default.
• W2898096704 hasConcept C2776802502 @default.
• W2898096704 hasConcept C2778041864 @default.
• W2898096704 hasConcept C2778336483 @default.
• W2898096704 hasConcept C2778461978 @default.
• W2898096704 hasConcept C2778729363 @default.
• W2898096704 hasConcept C2780235182 @default.
• W2898096704 hasConcept C2781413609 @default.
• W2898096704 hasConcept C530470458 @default.
• W2898096704 hasConcept C55493867 @default.
• W2898096704 hasConcept C71924100 @default.
• W2898096704 hasConcept C72563966 @default.
• W2898096704 hasConcept C90924648 @default.
• W2898096704 hasConceptScore W2898096704C104317684 @default.
• W2898096704 hasConceptScore W2898096704C121608353 @default.
• W2898096704 hasConceptScore W2898096704C126322002 @default.
• W2898096704 hasConceptScore W2898096704C143998085 @default.
• W2898096704 hasConceptScore W2898096704C150194340 @default.
• W2898096704 hasConceptScore W2898096704C185592680 @default.
• W2898096704 hasConceptScore W2898096704C190727270 @default.
• W2898096704 hasConceptScore W2898096704C2776012956 @default.
• W2898096704 hasConceptScore W2898096704C2776239401 @default.
• W2898096704 hasConceptScore W2898096704C2776611710 @default.
• W2898096704 hasConceptScore W2898096704C2776694085 @default.
• W2898096704 hasConceptScore W2898096704C2776802502 @default.
• W2898096704 hasConceptScore W2898096704C2778041864 @default.
• W2898096704 hasConceptScore W2898096704C2778336483 @default.
• W2898096704 hasConceptScore W2898096704C2778461978 @default.
• W2898096704 hasConceptScore W2898096704C2778729363 @default.
• W2898096704 hasConceptScore W2898096704C2780235182 @default.

• next